Odonate Therapeutics, Inc. (ODTC)

OTCMKTS: ODTC · Delayed Price · USD
3,500.00
+75.00 (2.19%)
Apr 8, 2024, 3:27 PM EDT - Market closed
Market Cap 67.36M
Revenue (ttm) n/a
Net Income (ttm) -112.49M
Shares Out 19.25K
EPS (ttm) -5,986.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1
Open 3,500.00
Previous Close 3,425.00
Day's Range 3,400.01 - 3,500.00
52-Week Range 3,400.01 - 49,895.00
Beta -0.21
Analysts n/a
Price Target n/a
Earnings Date n/a

About ODTC

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Dec 7, 2017
Employees 137
Stock Exchange OTCMKTS
Ticker Symbol ODTC
Full Company Profile

Financial Performance

Financial Statements

News

Grabar Law Office Investigates Potential Claims Against Officers and Directors of Odonate Therapeutics, Inc. After an Agreement to Settle Class Action for $12.5 Million

Philadelphia, Pennsylvania--(Newsfile Corp. - May 26, 2022) - Odonate Therapeutics Inc. (NASDAQ: ODT) (OTC: ODTC) has agreed to pay $12.5 million to resolve a proposed securities class action in alleg...

2 years ago - Newsfile Corp

Grabar Law Office Investigates Potential Claims Against Officers and Directors of Odonate Therapeutics, Inc. After an Agreement Is Reached to Settle Class Action

Philadelphia, Pennsylvania--(Newsfile Corp. - May 10, 2022) - Odonate Therapeutics Inc. (NASDAQ: ODT) (OTC Pink: ODTC) has agreed to pay $12.5 million to resolve a proposed securities class action in ...

2 years ago - Newsfile Corp

Odonate Announces Expected Delisting of Its Stock

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying Odonate tha...

2 years ago - Business Wire

Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that it will commence a share repurchase plan for up to 20 million shares in order to return capital to stockholders...

2 years ago - Business Wire

Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and nine months ended September 30, 2021. As of September 30, 2021, Odonate had $95....

2 years ago - Business Wire

SHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to Investors

SAN FRANCISCO, Aug. 13, 2021 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Odonate Therapeutics, Inc. (NASDAQ: ODT) relating ...

2 years ago - PRNewsWire

The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $ODT #investors--The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors

2 years ago - Business Wire

Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and six months ended June 30, 2021. In March 2021, Odonate announced the discontinua...

2 years ago - Business Wire

Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today

Odonate Therapeutics, Inc. (NASDAQ: ODT), Opthea Limited (NASDAQ: OPT), ALX Oncology Holdings Inc. (NASDAQ: ALXO), Provention Bio, Inc. (NASDAQ: PRVB) and Advaxis, Inc. (NASDAQ: ADXS) are among the bi...

Other symbols: ADXSALXO
3 years ago - Benzinga

Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three months ended March 31, 2021. Odonate recently announced the discontinuation of devel...

3 years ago - Business Wire

Why GRPN Stock And ODT Stock Are Trading Lower Today

Groupon Inc (NASDAQ: GRPN) shares are trading lower Monday after the company announced a proposed private offering of $200 million of convertible senior notes. Groupon acts as the middleman between co...

Other symbols: GRPN
3 years ago - Benzinga

Odonate Therapeutics stock plummets toward record low after plan to 'wind down' operations

Shares of Odonate Therapeutics Inc. plummeted 79.0% in active afternoon trading Monday, after the pharmaceutical company said it will wind down operations following disappointing data from its cancer ...

3 years ago - Market Watch

Why Odonate, Marker Therapeutics and Dyadic Are Moving Monday

Odonate Therapeutics, Inc. (NASDAQ: ODT), Dyadic International, Inc. (NASDAQ: DYAI) and Marker Therapeutics, Inc. (NASDAQ: MRKR) are among the early biotech movers in Monday's session. Odonate to Shut...

Other symbols: DYAIMRKR
3 years ago - Benzinga

Odonate Therapeutics Announces Discontinuation of Development of Tesetaxel

NEW YORK--(BUSINESS WIRE)--Following feedback from the U.S. Food and Drug Administration (FDA) in a pre-New Drug Application meeting, Odonate Therapeutics, Inc. (NASDAQ: ODT) has concluded that the cl...

3 years ago - Business Wire

Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients w...

3 years ago - Business Wire

Notable Insider Buys Of The Past Week: Danimer Scientific, Cheniere Energy Partners And More

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can...

3 years ago - Benzinga

3 Beaten-Down Stocks Insiders Scooped Up as 2020 Ended

Fidelity National, Odonate Therapeutics, and Steel Partners all sank by double-digit percentages in 2020. Company executives and directors bought up the stocks.

Other symbols: FNFSPLP
3 years ago - Barrons

Notable Insider Buys In The Week Of Christmas: Foot Locker, GameStop, NetApp And More

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can...

3 years ago - Benzinga

Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)

SAN DIEGO--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best‑in‑class therapeutics that improve and extend the lives of patients ...

3 years ago - Business Wire

Odonate Therapeutics Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monotherapy in Patients with Metastatic Breast Cancer

SAN DIEGO--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients ...

3 years ago - Business Wire

Odonate Therapeutics to Host Virtual Investor and Analyst Event on December 11, 2020

SAN DIEGO--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients ...

3 years ago - Business Wire

ODT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 16, 2020 in the Class Action Filed on Behalf of Odonate Therapeutics, Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - November 16, 2020) -  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Odonate Therapeutics, Inc. (NASDAQ: O...

3 years ago - Newsfile Corp

FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Odonate Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - November 16, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Odonate Ther...

3 years ago - Newsfile Corp

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Odonate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 16, 2020 - ODT

New York, New York--(Newsfile Corp. - November 16, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o...

3 years ago - Newsfile Corp

ODT Final Deadline Today: Rosen, Top Ranked National Investor Attorneys, Reminds Odonate Therapeutics, Inc. Investors of Important November 16 Deadline in Securities Class Action - ODT

New York, New York--(Newsfile Corp. - November 16, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Odonate Therapeutics, Inc. (NASDAQ: ODT) between D...

3 years ago - Newsfile Corp